My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$CELG {{ '2015-07-07T12:53:54+0000' | timeago}} • SEC

$CELG Form 4: Gilla Kaplan, Director of Celgene Corporation exercised 733 stock options, one-third of RSUs are granted to reporting person on July 1, 2014 vested and settled for shares of the company's common stock on July 1, 2015. Post transaction, he now owns 88,485 shares.

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

$UNM {{ '2016-10-28T01:04:46+0000' | timeago}} • Webcast

In 3Q16, $UNM reported net income of $236MM or $1.01 per share compared to $203.8MM or $0.83 per share for 3Q15. Total revenues were $2.76Bil, an increase compared to $2.65Bil last year.

$MCK {{ '2016-10-28T00:45:17+0000' | timeago}} • Webcast

In $MCK’s Technology Solutions segment, revenues were down 6% for 2Q17 to $680MM on a constant currency basis, driven by the anticipated decline in the hospital software business, partially offset by growth in other technology businesses.

$MCK {{ '2016-10-28T00:42:00+0000' | timeago}} • Webcast

In 2Q17, in $MCK’s Distribution Solutions segment, revenues grew 3% to $49.3Bil. North America pharmaceutical distribution and services revenues grew 2%  in constant currency. International pharmaceutical distribution and services revenues grew 12% in constant currency. Medical-Surgical revenues were up 4% in 2Q17.

$PFG {{ '2016-10-28T00:36:54+0000' | timeago}} • Announcement

$PFG said its BoD has authorized a quarterly common stock dividend of $0.43 per share for 4Q16, bringing the trailing 12-month dividend per share to $1.61, an 7% increase compared to last year. This dividend will be payable on Dec. 27, 2016, to shareholders of record as of Dec. 5, 2016.

$PFG {{ '2016-10-28T00:35:28+0000' | timeago}} • Announcement

$PFG's total asset under management, or AUM, as of Sept. 30, 2016 was $595.8Bil, with positive net cash flows of $19.8Bil. Principal Global Investors had total AUM of $397.3Bil, and Principal International had AUM of $136.3Bil, which excludes $127.2Bil of AUM in its joint venture in China that is not part of reported AUM.